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The human adenovirus E4orf6 and E1B55K proteins are part of an E3 ubiquitin ligase complex that degrades p53, Mre11 and probably other
cellular polypeptides. Our group has demonstrated previously that this complex contains Cul5, Rbx1 and Elongin B and C and is formed through
interactions of these cellular proteins with E4orf6. Although this E4orf6 complex is similar in many ways to the cellular SCF and VBC E3 ligase
complexes, our previous work indicated that unlike all known Cullin-containing complexes, E4orf6 contains two functional BC-box motifs that
permit interactions with Elongin B and C. Here we show that a third BC-box exists that also appears to be fully functional. In addition, we attempted
to identify a region in E4orf6 responsible for the specific selection of Cul5, which we show herein by knocking down Cul5 protein levels, is essential
for p53 degradation. One sequence within E4orf6 shares limited homology with the ‘Cul5 box motif’, a recently identified sequence found to be
responsible for selection of Cul5 in some cellular Cullin-containing E3 ligase complexes; however, genetic analysis indicated that this motif is not
involved in Cullin binding or p53 degradation. Thus E4orf6 appears to utilize a different mechanism for Cul5 selection, and, both in terms of
interactions with Elongin B and C and with Cul5, assembles the E3 ligase complex in a highly novel fashion.
© 2007 Elsevier Inc. All rights reserved.Keywords: Adenoviruses; E3 ligase complex; CullinsIntroduction
The human adenovirus type 5 (Ad5) early region 4 34 kDa
product from open reading frame 6 (E4orf6) and the E1B55K
protein have been known for some time to interact with p53
independently and to regulate p53 function (Dobner et al., 1996;
Nevels et al., 1997; Querido et al., 1997; Sarnow et al., 1982;
Yew and Berk, 1992). In addition, E4orf6 and E1B55K function
in concert to induce the degradation of p53 (Cathomen and
Weitzman, 2000; Querido et al., 1997; Roth et al., 1998;
Steegenga et al., 1998;Wienzek et al., 2000).We and others have
shown that this process occurs through the formation of an E3
ligase complex containing the Cullin family member Cul5,⁎ Corresponding author. Department of Biochemistry, McGill University,
McIntyre Medical Building, 3655 Promenade Sir William Osler, Montreal,
Quebec, Canada H3G 1Y6. Fax: +1 514 398 8845.
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doi:10.1016/j.virol.2007.02.012Elongin B and C and the RING protein Rbx1, which were shown
to form a complex through interactions with E4orf6 but not
E1B55K (Blanchette et al., 2004; Harada et al., 2002; Querido et
al., 2001a). Cullin-based E3 ligases are part of the RING-type
group of E3 ligases, which are composed of a Cullin family
member and the RING protein Rbx1 linked to a protein that acts
as a substrate specificity factor. These complexes interact with an
E2 conjugating enzyme, often either Cdc34 or Ubc5, to
conjugate ubiquitin chains to their substrate. In the case of the
SCF complex, for which a crystal structure has been determined
(Zheng et al., 2002), Cul1 is linked by Skp1 to one of many F-
box proteins, which serve as the substrate recognition protein
(reviewed in Cardozo and Pagano, 2004; Jackson and Eldridge,
2002). In the VBC complex, the linker proteins Elongin B and C
link Cul2 to the substrate specificity protein VHL. Elongin B and
C also serve as a linker for complexes of Cul5, which have been
found to exist with presumed substrate specificity proteins
Muf1, Elongin A, WSB and SOCS1 (Kamura et al., 2001),
Fig. 1. BC-box motifs in Ad5 E4orf6. (A) Diagramatic representation of the
E4orf6 protein with the amino (N-Term) and carboxy (C-Term) termini and BC-
boxes 1, 2 and 3 indicated. Also noted is the potential Cul5-box-like sequence
(see more in Fig. 4A). (B) Cellular BC-box consensus sequence (Kamura et al.,
1998, 2001) and HIV-1 Vif BC-box motif (Yu et al., 2004). (C) E4orf6 BC-box
sequences.
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identified. In addition to p53, the E4orf6-E1B55K-Cullin E3
ligase also degrades Mre11 (Blanchette et al., 2004; Stracker et
al., 2002), and it is widely believed that other substrates also
exist that are, like Mre11 and p53, directed to the complex
through interactions with E1B55K (Blanchette et al., 2004;
Carson et al., 2003; Woo and Berk, 2007). In this context we
have suggested that the degradation of certain of these substrates
may be responsible for other functions attributed to E4orf6-
E1B55K, including control of mRNA transport and stability and
host cell shut-off, as E1B55K appears only to interact with
E4orf6 in the context of the E3 ligase complex (Blanchette et al.,
2004).
Elongin C-interacting proteins, including Elongin A, VHL
and SOCS1, have been shown to contain a conserved sequence,
termed the BC-box motif, which is the only region of significant
homology between Elongin A and VHL and which is required
for interaction with Elongin C (Kamura et al., 1998, 2001). In
recent studies on the E4orf6 E3 ligase complex, we showed that
E4orf6 is unique in that it contains two such near-consensus
BC-box motifs that are both needed for efficient E1B55K/
E4orf6-induced degradation of p53 and Mre11.
Until recently, little was known about the mechanism by
which specific Cullin family members are selected in the
formation of Cullin-containing E3 ubiquitin ligase complexes.
In a recent study, cellular Cullin-specific binding sequence
motifs were identified within the SOCS box protein of the ECS
(Elongin B/C-Cul2/Cul5-SOCS box protein) and VHL that are
responsible for interactions with either Cul2-Rbx1 or Cul5-
Rbx1 (Kamura et al., 2004).
In the present studies we have investigated further the
mechanism of formation of the E4orf6-Cul5 E3 ligase. First, a
sequence in E4orf6 was noted just downstream of BC-box 2 that
resembled a variant BC-box motif found in the Vif protein of
HIV-1 (Yu et al., 2004), and it was shown to represent a third
functional BC-box. Secondly, the role of an E4orf6 sequence
resembling the newly described Cul5 box motif was noted, but
mutational analysis indicated that this sequence plays no role in
the selective recruitment of Cul5.
Results
Identification of a third functional BC-box in Ad5 E4orf6
As described previously, the Ad5 E4orf6 product is the only
protein known to contain two functional BC-boxes, that are
located between residues 46–55 (BC-box 1) and 121–130 (BC-
box 2) (Blanchette et al., 2004) (see Fig. 1A). These sequences
resemble BC-box motifs in VHL, Elongin A, SOCS1 and other
interacting cellular proteins with a consensus amino acid
sequence of (A,P,S,T)LxxxCxxx(A,I,L,V), where the L and C
residues are invariable (Duan et al., 1995; Kamura et al., 1998).
Alteration of the conserved L and C residues within these motifs
resulted in a reduction or loss of binding to Elongin B and C
and, in combination with Ad5 E1B55K, failure to degrade p53
and Mre11 (Blanchette et al., 2004). After this work had been
completed a variant form of Elongin B/C binding motif with theconsensus sequence SLQxxAxxx(V,L) was identified in the
HIV-1 protein Vif, a viral polypeptide involved in the
degradation of APOBEC3G, which induces hypermutations in
newly synthesized viral DNA, through the formation of a Cul5-
ElonginB/C E3 ubiquitin ligase (Yu et al., 2004). This sequence
resembles the cellular BC-box motif except that the conserved C
residue located four amino acids downstream of the L is
substituted by A. It was suggested that residues with short side
chains such as C and A but not those with longer side chains
might serve in this position (Yu et al., 2004). The E4orf6 protein
contains such a sequence just downstream of BC-box 2 at
residues 131–140 (see Figs. 1A and B), suggesting that a third
BC-box could be present in E4orf6.
To determine if this motif in E4orf6 is functional in complex
formation, a mutation was created in the coding sequence of a
cDNA expressing E4orf6 that converted L132 to an A residue
(L132A-BC3), and this form of E4orf6 as well as another in
which the critical L residues of all BC-boxes had been altered
(L47G/L122S/L132A-BC123) was studied. As in previous
studies (Blanchette et al., 2004), p53-null H1299 cells were
transfected with plasmid DNAs expressing wild-type (wt) or
mutant forms of E4orf6 listed in Fig. 2, and interactions of
E4orf6 species with Elongin C were determined by co-
immunoprecipitation using anti-E4orf6 antibody followed by
western blotting using anti-Elongin C antibodies (Fig. 2A). All
mutant forms of E4orf6 and wt E4orf6 were expressed at high
levels. As seen previously (Blanchette et al., 2004; Querido et
al., 2001a), immunoprecipitation of wt E4orf6 resulted in the
co-immunoprecipitation of Elongin C. Also as found pre-
viously, alteration of L47 in E4orf6 BC-box 1 to G (L47G-BC1)
had little effect on binding to Elongin C, but the L122S-BC2
mutant failed to form stable interactions with Elongin C as did,
importantly, mutant L132A-BC3 within putative BC-box 3 and
the triple-box leucine mutant (L47G/L122S/L132A-BC123).
Similar studies were conducted to measure binding of E4orf6 to
Cul5. Fig. 2B shows that with Cul5 a binding pattern with the
Fig. 2. Functional analysis of E4orf6 proteins with an alteration in putative BC-box 3. H1299 cells were transfected with plasmid DNAs expressing wt or mutant forms
of E4orf6 and cell extracts or immunoprecipitates prepared using anti-E4orf6 antibody (as indicated in the figure) were analyzed by SDS-PAGE followed by western
blotting using appropriate antibodies. (A) Binding to Elongin C. The levels of Elongin C present in the E4orf6 immunoprecipitates (top panel) were determined by
blotting using anti-Elongin C antibodies. Levels of E4orf6 and Elongin C in whole cell extracts (bottom two panels) were determined by western blotting using anti-
E4orf6 or anti-Elongin C antibodies, respectively. (B) Binding to HA-Cul5. H1299 cells were co-transfected with plasmid DNAs expressing HA-Cul5 and wt or
mutant forms of E4orf6 and whole cell extracts and immunoprecipitates prepared using anti-E4orf6 antibodies were analyzed as in panel A except that HA-Cul5 was
detected using anti-HA antibodies. (C) Binding to p53. Cells as in panel Awere co-transfected with plasmid DNA expressing HA-tagged human p53 and whole cell
extracts and immunoprecipitates prepared using anti-E4orf6 antibodies were analyzed as in panel A except that HA-p53 was detected using anti-HA antibodies. (D)
Degradation of p53. H1299 cells were co-transfected with plasmid DNAs encoding human wt p53, E1B55K and wt or mutant forms of E4orf6. Degradation of p53 was
assessed at 24 h post-transfection by western blotting of whole cell extracts separated by SDS-PAGE using anti-p53 antibodies (top panel). The levels of E1B 55K,
E4orf6 and actin (bottom three lanes) were determined by western blotting using antibodies directed against each.
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failure of these mutant polypeptides to interact with Elongin C
and Cul5 did not appear to be the result of major conformational
changes in the E4orf6 protein as all species were found to
interact with p53 at levels similar to wt E4orf6 in H1299 cells
co-expressing HA-tagged human p53 (Fig. 2C). These results
indicated that the putative BC-box 3 (BC3) appears to be
important for binding both Elongin C and Cul5.
To examine the effect of BC-box mutations in E4orf6 on the
ability of the E4orf6-E1B55K E3 ligase complex to promote
degradation of p53, a degradation assay was used in which
H1299 cells were transiently co-transfected with plasmid DNAs
encoding human wt p53, E1B55K and wt or mutant forms of
E4orf6. Degradation of p53 was assessed at 24 h post-
transfection by western blotting using anti-p53 antibodies.
Although the results varied slightly between experiments,
representative results from many p53 degradation assays are
shown in Fig. 2D. As found previously, and unlike the double
mutant in BC1 (L47G/C51S-BC1) which was only partially
active (Blanchette et al., 2004), mutant L47G-BC1 was seen tobe functionally wild-type in its ability to degrade p53; however,
the other E4orf6 mutants, including L132A-BC3 were to
varying degrees partially defective in promoting p53 degrada-
tion, with the triple-box leucine mutant (L47G/L122S/L132A-
BC123) affecting all three BC-boxes being most highly
defective. We should note that even though a partial defect in
p53 degradation is shown with mutant L132A-BC3 in Fig. 2D,
levels of activity similar to those seen with wild-type were
observed occasionally in some experiments (data not shown).
Thus, especially considering the lack of complex interaction
observed in our studies, overall our results strongly suggested
that BC-box 3 is functional and that all BC-boxes contribute to
promoting p53 degradation.
Sequence requirements in E4orf6 BC-box 3
Analysis of the sequences of Vif proteins from various
groups of HIV-1 and SIV lentiviruses indicated a high degree of
conservation of the S/TLQ sequence (Yu et al., 2004). Such is
not the case in cellular BC-box motifs in which only the L has
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SLQ sequence in HIV-1 and SIV Vif proteins relates to the
common evolutionary origins of these proteins or if the optimal
interaction with Elongin B and C requires the SLQ sequence. To
study this issue in the E4orf6 BC-box 3 sequence, additional
E4orf6 mutants were prepared in which the SLQ residues were
all converted to A residues (SLQ131,132,133AAA-BC3), and
biological activity was compared to that of L132A-BC3 both
alone and in the context of mutations in BC-boxes 1 and 2, in
studies that exactly paralleled those in Fig. 2. Fig. 3 confirms
results in Fig. 2 that the L132A-BC3 mutant appeared entirely
defective in forming stable interactions with both Elongin C
(Fig. 3A) and Cul5 (Fig. 3B), as was SLQ131,132,133AAA-
BC3 and the triple box mutants. All mutants were found to be
capable of binding p53 (Fig. 3C), again suggesting that none
contained major conformational changes. Although no apparent
differences were observed between the L132A-BC3 and
SLQ131,132,133AAA-BC3 forms of E4orf6 in terms of
binding to Elongin C, Cul5 or p53, such was not the case
when studies were conducted to measure the degradation of p53
in concert with the E1B55K protein (Fig. 3D). As was the caseFig. 3. Functional analysis of E4orf6 proteins with alterations in BC-box 3. Studies i
alterations in the SLQ motif of BC-box 3.in Fig. 2D, degradation of p53 relative to wt E4orf6 was barely
or only partially reduced with L132A-BC3, whereas p53
degradation was clearly defective with SLQ131,132,133AAA-
BC3, suggesting that in addition to L132, the S131 and Q133
residues in BC-box 3 were also important. The results of this
part of the present report thus indicate that E4orf6 contains three
functional BC-boxes and that BC-box 3 resembles the motif
present in HIV-1 Vif in that the S and Q amino acids directly
adjacent to the critical L residue are of functional importance.
Analysis of a putative Cul5 Box in E4orf6
Studies on a number of Cullin containing E3 ligase
complexes, including our work on the E4orf6-Elongin B/C-
Cul5 complex, indicated that these complexes contain exclu-
sively just one member of the Cullin family (Blanchette et al.,
2004; Kamura et al., 2001, 2004). Recent elegant studies,
including domain swapping experiments, with the SOCS box
protein of the ECS and VHL complexes have now identified the
consensus sequence motifs responsible for interactions with
Cul2-Rbx1 or Cul5-Rbx1 that are presumably responsible fordentical to those described in Fig. 2 were conducted using E4orf6 proteins with
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E3 ligase complexes (Kamura et al., 2004). Our group has
shown that Cul5 is by far the predominant Cullin species
present in the E4orf6 E3 ligase complex (Querido et al., 2001a),
although careful examination has detected very low levels of
Cul2 as well (C. Y. Cheng, unpublished results). The consensus
Cul5 box motif in cellular Cul5-binding proteins has been
defined as (V,I)xxLPxPxx(I,L)xxxL with the LPxP sequence,
especially the second P, being essential (Kamura et al., 2004).
E4orf6 does not contain the motif LPxP and the only sequence
with any similarity is contained within a region just downstream
of BC-box 1 at 62VRGLPCSVGFTLI74, as shown in Fig. 4A.
Although this motif contains S in place of the essential second P
residue, it was possible that it could represent a degenerate but
functional Cul5 box. To assess the role of this sequence in Cul5
binding and the formation of a functional E4orf6 E3 ligase
complex, a series of mutants was prepared and tested in the
same kind of assays involving DNA transfection as described in
Figs. 2 and 3. First, S68 was converted to P in mutant S68P to
recreate a perfect LPxP motif found in cellular Cul5 boxes. This
mutation might be expected to enhance Cul5 binding as was
seen with a similar mutation in the SOCS1 protein (Kamura et
al., 2004). Second, residues L65 and P66 were converted to A
(LP65,66AA), and then these changes were combined with
mutations that converted L73 and I74 to A residuesFig. 4. Functional analysis of the Cul5 box-like motif in E4orf6. (A) Cellular Cul5 box
E) Studies identical to those described in Fig. 2 were conducted using cells expressin
indicated in the figure.(LP65,66AA/LI73,74AA) and V62 to A (V62A/LP65,66AA/
LI73,74AA). Fig. 4 shows the results of studies that strongly
suggest that the region between residues 62 to 74 is not involved
in binding of Cul5. First, mutant S68P, which might have been
expected to exhibit enhanced Cul5 binding, was extremely
defective in interactions with both Cul5 (Fig. 4B) and Elongin C
(Fig. 4C), although it still was capable of interacting with p53
(Fig. 4D) and of inducing the degradation of p53 in the presence
of E1B55K (Fig. 4E). All other mutants exhibited a wt
phenotype for binding of Cul5 (Fig. 4B), Elongin C (Fig. 4C)
and p53 (Fig. 4D), and were able to promote p53 degradation in
the presence of E1B55K like wt E4orf6 (Fig. 4E). These results
indicated that this putative Cul5 box motif is non-functional,
and thus Cul5 binding must reside in another region of E4orf6.
Cul5 is essential for E4orf6-E1B55K-dependent degradation of
p53
Although considerable evidence suggests that p53 is
degraded by E4orf6 and E1B55K via the formation of an E3
ligase complex containing Cul5, it nevertheless remained
possible that other Cullin family members may function with
E4orf6 through the formation of complexes at low levels or via
transient interactions that are not preserved under our conditions
of immunoprecipitation. To examine the specific requirement(Kamura et al., 2004) and Cul5 box-like sequences in E4orf6 are indicated. (B–
g wt E4orf6 or mutant forms with alterations in various residues in the motif, as
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express Cul5-specific short hairpin RNAi. As described in
Materials and Methods, H1299 cells were co-transfected with
plasmid DNA that expresses an interfering RNA species
specific for Cul5 or with control vector DNA in addition to a
plasmid DNA expressing the puromycin resistance gene.
Following puromycin selection, cell clones were tested for
expression of Cul5 by western blotting. Fig. 5A shows that the
level of expression of Cul5 was considerably lower in the Cul5
knockdown (KD) line expressing RNAi than in normal H1299
cells or a control line; however, the levels of expression of
Elongin B and C were unaffected by the expression of the RNAi
constructs (Fig. 5B), demonstrating the specificity of the RNAi.
These cells were then co-transfected with plasmid DNAs
expressing wt E4orf6, E1B55K and human wt p53, and p53
levels were measured as in Figs. 2–4. Fig 5C shows that in
vector control H1299 cells p53 degradation was considerable in
the presence of both E4orf6 and E1B55K; however, in the Cul5
KD line little or no p53 degradation was evident. These results
confirmed that Cul5 is essential and is probably the only Cullin
family member of importance in this process.
Discussion
In this report we demonstrate that although the architecture
appears generally similar to a number of cellular Cullin-Fig. 5. Requirement for Cul5 in the degradation of p53 by E4orf6 and E1B55K. (A) N
Cul5 (Cul5 KD) or a control RNAi plasmid (Control) were prepared as described in M
western blotting using anti-Cul5 antibodies (top panel) and that of actin using anti-ac
whole cell extracts as in panel Awere determined by western blotting using anti-Elong
similar to those described in Fig. 2D were conducted in Control and Cul5 KD cellscontaining E3 ubiquitin ligase complexes, the manner in which
the adenovirus protein E4orf6 assembles its complex is novel.
Previous studies indicated that the E3 ligase complex formed by
E4orf6 greatly resembled the architecture of the Cullin-based
complexes, in particular the VBC complex (Blanchette et al.,
2004; Harada et al., 2002; Querido et al., 2001a). It utilizes a
Cullin component (Cul5) linked to E4orf6 (the substrate
specificity protein) through the linker proteins Elongin B and
C (Harada et al., 2002; Querido et al., 2001a). Like VHL, E4orf6
bound to Elongin C, but with the difference that E4orf6 contains
two BC-box motifs whereas VHL (and other Elongin C-binding
proteins) contain only one. In the present report we have shown
that a third functional BC-box exists in E4orf6 just downstream
of the second. This BC-box differs from classical cellular BC-
boxes and is in fact identical to the BC-box identified in the HIV
VIF protein (Yu et al., 2004). In the VIF protein, this “viral” BC-
box motif is the only one found and alterations in this sequence
were sufficient to abolish the ligase activity (Yu et al., 2004).
Although the L mutant in BC-box 1 (L47G-BC1) was still
able to induce p53 degradation with E1B55K like wt E4orf6
(Fig. 2), BC-box 1 is believed to be functional as we have
shown previously that the double mutant in BC-box 1 (L47G/
C51S-BC1) was only partially effective in the p53 degradation
assay (Blanchette et al., 2004).
The reasons why the viral E4orf6 protein would require three
functional BC-boxes, of two different types remain unclear,ormal H1299 cells (H1299) or those constitutively expressing RNAi specific for
aterials and Methods. The level of Cul5 in whole cell extracts was determined by
tin antibodies (bottom panel). (B) The levels of Elongin B and C from the same
in B and anti-Elongin C antibodies, respectively. (C) Degradation of p53. Studies
.
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that it can only bind to one BC-box at a time (Stebbins et al.,
1999). One possibility might be that the third BC-box of
E4orf6 may bind at a different site in Elongin C, thus allowing
for two simultaneous interactions, one with the normal cellular
BC-box and a second with the viral form of the BC-box and
making the Elongin C/E4orf6 interaction more stable or of
higher affinity. This enhanced binding or simply the avail-
ability of three binding sites could also allow E4orf6 to more
readily compete with cellular proteins for Elongin C binding
and E3 ligase complex formation. In any case, the viral BC-
box motifs found in both Vif and E4orf6 differ from cellular
sequences in that two additional amino acids, the conserved
residues S and Q, appear to be involved in the Elongin C
interaction. The present results with E4orf6 strongly suggest
that these additional amino acids are part of a “viral SLQ
motif” for optimal interaction with Elongin C and are not
present in the HIV-1 and SIV Vif proteins just because of the
common evolutionary origins of these polypeptides. It is
interesting to note that the SLQ motif in E4orf6 is also very
well conserved among the different human adenoviral
serotypes, suggesting that perhaps the E4orf6 proteins of all
serotypes form E3 ligases and utilize a similar array of BC-
boxes. Finally, it is unclear if there is a hierarchy of usage of
the various E4orf6 BC-boxes; however, alteration of residues
in boxes 2 and 3 appears to affect function more than with box
1, suggesting that these may be of more functional importance
than BC-box 1.
We also tried to identify the motif in E4orf6 that provides
Cul5 binding specificity (Cul5-box) as the Elongin B and C
proteins can also serve as a linker for Cul2 (Kamura et al.,
2004). Only one sequence in E4orf6 exhibited partial homology
to the recently described cellular Cul5-box (Fig. 4A). The
results of our genetic analysis of this E4orf6 sequence indicated
that this putative Cul5-box is not functional since all mutations
designed to abolish the interaction failed to do so. In addition,
the S68P mutant designed potentially to enhance the interaction
by creating the consensus LPxP motif (Kamura et al., 2004)
failed to bind stably to Elongin C and Cul5, although it was still
able to promote p53 degradation. This mutant form of E4orf6
interacted with p53, suggesting that introduction of the P
residue did not affect conformation greatly, at least in the
regions required for interaction with p53. As we have seen with
some of the BC-box 1 and 2 mutants (Blanchette et al., 2004), it
seems likely that the S68P mutant interacts with Elongin C and
Cul5 either transiently or in a fashion that is not stable to
purification by immunoprecipitation. Although S68P was seen
to interact with p53, the introduction of a P residue at S68 may
have altered the conformation of E4orf6 sufficiently to have
affected the region(s) involved in interactions with Elongin C
and Cul5.
As E4orf6 appears to lack a traditional Cul5-box, it must
select for Cul5 in a different fashion. The HIV protein Vif also
selects for Cul5 in a Cul5-box-independent manner. In this case,
a novel zinc finger motif (Hx5Cx17–18Cx3–5H) was found to be
required for Cul5 binding (Mehle et al., 2006; Yu et al., 2004).
Mutants of this motif could still interact with Elongin B and C(BC-box intact) but could not interact with Cul5 (Yu et al.,
2004). Although E4orf6 contains many histidine and cysteine
residues and it was shown to bind zinc (Boyer and Ketner,
2000), we could not find a similar zinc finger motif in
E4orf6. Additionally, mutants containing alterations in many
of these H and C residues have been generated previously
(Boyer and Ketner, 2000) and the mutant E4orf6 proteins
were tested for complex formation (Blanchette et al., 2004).
All were found to be either unstable, or unable to interact
with Elongin C, making it very unlikely that they are part of a
Cul5-box. Finally, a recent report suggested that this zinc
finger motif may be specific for the Vif protein (Xiao et al.,
2007). Although the Cul2- and Cul5-boxes determine Cullin
specificity in Cul2- and Cul5-based ligase complexes, the
interaction of the substrate specificity protein to the Cullin
through the Elongin B/C linker is probably much stronger
than the direct association of the Cullin with the Cul2/5-box
since all mutations within BC-boxes that abrogate interaction
with Elongin C also abrogate interaction with the Cullin
(Blanchette et al., 2004). Further genetic analysis will be
required to identify the regions in E4orf6 responsible for
interaction with or selection of Cul5.
As we have been unable so far to identify a Cul5-box in
E4orf6, we felt it necessary to confirm with a functional assay
that E4orf6 indeed uses Cul5 in its E3 ubiquitin ligase complex.
Using plasmid-based RNAi, we were able to produce a cell line
in which the level of Cul5 was drastically reduced, suggesting
that cellular Cul5-based E3 ligases are not essential for cell
viability in culture, at least with the H1299 cell line. Using this
Cul5 knock-down cell line, we were able to show clearly that
degradation of the p53 substrate by the E4orf6 ligase complex is
highly dependent on Cul5.
Thus in order to degrade p53 and presumably other target
proteins, E4orf6 assembles a Cul5-based E3 ligase complex in
an apparently unique fashion in terms of interactions with both
Elongin B and C and Cul5.
Materials and methods
Cells and cell lines
Human non-small cell carcinoma H1299 cells (ATCC CRL-
5803), carrying a homologous deletion of the p53 gene
(Mitsudomi et al., 1992), were cultured in alpha minimal
essential medium (Gibco) supplemented with 10% fetal calf
serum (FCS; Gibco) containing 100-U/ml penicillin and
streptomycin, 0.292-mg/ml L-glutamine (Gibco). The H1299-
Cul5 knockdown cell line (H1299 Cul5 KD) was generated by
co-transfection with plasmid DNAs expressing RNAi against
Cul5, which was previously verified for Cul5 RNAi efficiency
in transient transfection studies, and with pcDNA3-puro
(encoding the gene for puromycin resistance) at the ratio of
10:1, followed by selection in medium containing 2 μg/ml
puromycin. Individual colonies were picked and expanded, and
the level of expression of endogenous Cul5 was verified by
western blotting using antibody against Cul5. A clone that
showed the greatest reduction in expression level of Cul5 was
43C.Y. Cheng et al. / Virology 364 (2007) 36–44chosen for further experiments and maintained in the presence
of 1 μg/ml puromycin. The H1299-control cell line was
generated by transfection with plasmid DNAs pcDNA3 and
pcDNA3-puro at the ratio of 10:1, followed by selection in
medium containing 2 μg/ml puromycin.
Plasmids
BC-Box mutants L47G and L122S were described pre-
viously (Blanchette et al., 2004). Other BC-Box E4orf6 mutants
were generated by PCR-based mutagenesis using the following
oligonucleotide primers: L132A forward, CATTGTTC-
CAGTCCCGGTTCCGCACAGTGTATAGCCGGCGGG, and
reverse CCCGCCGGCTATACACTGTGCGGAACCGG-
GACTGGAACAATG, using pcDNA-E4orf6 as template;
LLL47,122,132GSA forward, CATTGTTCCAGTCCCGGTT-
CCGCACAGTGTATAGCCGGCGGG, and reverse CCCGCC-
GGCTATACACTGTGCGGAACCGGGACTGGAACAATG,
using pcDNA3-E4orf6 double mutant LL47,122GS which was
described previously (Blanchette et al., 2004) as template;
SLQ131,132,133AAA forward, CTGTCATTGTTCCAG-
TCCCGGTGCAGCAGCAGCATGTATAGCCGGCGGG-
CAG, and reverse CTGCCCGCCGGCTATACATGCTGCTG-
CACCGGGACTGGAACAATGACAG, using pcDNA-E4orf6
as template; L47G/L122S/SLQ131,132,133AAA forward,
CTGTCATTGTTCCAGTCCCGGTGCAGCAGCAGCATG-
TATAGCCGGCGGGCAG, and reverse CTGCCCGCCGG-
CTATACATGCTGCTGCACCGGGACTGGAACAATGA-
CAG, using pcDNA3-E4orf6 double mutant LL47,122GS as
template. Cul5Box mutants were generated by PCR-based
mutagenesis using the following oligonucleotide primers: S68P
forward, GTGCGAGGTCTTCCCTGCCCGGTGGGATTT-
ACGCTGATTC, and reverse GAATCAGCGTAAATCCCAC-
CGGGCAGGGAAGACCTCGCAC, using pcDNA3-HACul5
as template; LP65,66AA forward, GTGAGTTACGTGCGAG-
GTGCAGCATGCAGTGTGGGATTTACGCTG, and reverse
CAGCGTAAATCCCACACTGCATGCTGCACCTC-
GCACGTAACTCAC, using pcDNA3-HACul5 as template;
LP65,66AA/LI73,74AA forward, GCATGCAGTGTGGGATT-
TACGGCAGCACAGGAATGGGTTGTTCCCTGG, and
reverse CCAGGGAACAACCCATTCCTGTGCTGCCG-
TAAATCCCACACTGCATGC, using LP65,66AA as template;
V62A/LP65,66AA/LI73,74AA forward, GCACAATGTTTCC-
TACGCACGAGGTGCTGCATGCAGTGTGGG, and reverse
CCCACACTGCATGCAGCACCTCGTGCGTAGGAAA-
CATTGTGC, using LP65,66AA/LI73,74AA as template.
Short hairpin RNAi plasmid against Cul5 was generated
using the system from Dr. Hannon with the following primers:
forward GGCCAGATCTGATTTAGGTGACACTATAG, and
reverse GGAATTCAAAAAACACACCAACTTCTCCTAAC-
CACTCTACCCCAAGGTAGAGTGGCTAAGA -
GAAGTTGGTATGCTAGTATATGTGCTGCCGAAGC. The
pGEM zeo-U6 containing the pol III promoter U6 and the
zeocine cassette was used as template for the PCR (generous
gift from Dr. Greg Hannon). The resulting PCR product was
cloned into the pcDNA3 vector at the Bglll and EcoR1 site
replacing the pCMV promoter.Antisera
Description of E4orf6-specific rabbit polyclonal antibody
1807 was given previously (Boivin et al., 1999). Anti-p53
pAb1801 hybridoma supernatants was prepared as described
previously (Querido et al., 2001b). E1B55K was detected with
the 2A6 monoclonal antibody (Sarnow et al., 1982), Elongin C
with mouse monoclonal antibody SIII p15 (Transduction
Laboratories), HA epitopes with anti-HA mouse monoclonal
HA.11 (BAbCO) and Cul5 with rabbit polyclonal anti-Cul5
antibody (H-300) (Santa Cruz Biotechnology).
DNA transfection
Cells were transfected in 60- or 100-mm-diameter dishes
with liposome reagent DMRIE-C (Gibco-BRL), as described by
the manufacturer. For p53 degradation assays, 0.5 μg of
pcDNA3-p53, 1 μg of pcDNA3-E4orf6 (wt or mutants) and
1 μg of pcDNA3-E1B55K were transfected into cells on 60 mm
dishes with 7.5 μl of reagent for 24 h. When required, the total
amount of DNAwas made up to 2.5 μg by addition of pcDNA3
empty vector DNA. For binding assays, 2 μg of each of the
plasmid DNAs was transfected into cells on 100-mm-diameter
dishes using 12 μl of reagent.
Immunoprecipitation and western blotting
Cells were lysed for 20 min on ice with lysis buffer (20 mM
Tris–HCl, pH 7.5, containing 150 mM NaCl, 2 mM EDTA, 1%
Triton X-100, 5% glycerol, 2 mM DTT, 4 mM NaF, 2 mM
NaPP, 500 μM Na3VO4, 200 μg/ml PMSF, 2 μg/ml aprotinin,
5 μg/ml leupeptin). For binding assays and degradation assays,
aliquots of cell extract containing 30 μg of protein were loaded
onto sodium dodecyl sulfate polyacrylamide gels for electro-
phoresis (SDS-PAGE) followed by western blotting analysis, or
between 400 and 800 μg (constant with each experiment) was
used for immunoprecipitation using 5 μl of rabbit anti-E4orf6
polyclonal antibody 1807, followed by incubation with protein
G Sepharose (Amersham Bioscience). The beads were
extensively washed in lysis buffer and examined by SDS-
PAGE. Proteins separated on the gels were then transferred to
PVDF membranes. Membranes were incubated with the
indicated primary antibodies in 1% TBST with 1% non-fat
dry milk, followed by appropriate peroxidase-conjugated
secondary antibody with dilution 1 in 10,000 (Jackson
ImmunoResearch Laboratories). Membranes were then visua-
lized by enhanced chemiluminescence with ECL plus western
blotting reagents (Amersham-Pharmacia Biotech). For determi-
nation of endogenous Cul5 level in the stable cell lines, 120 μg
of proteins were loaded on the SDS gels and treated the same
way as other protein gels described above.
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